Model reveals altered matrix assembly and upregulation of cholesterol biosynthesis in MED, highlighting potential therapies.
Our model revealed mutant matrilin-3 induces cholesterol biosynthesis pathway upregulation and abnormal matrix assembly during MED pathogenesis. This study provides new insights into the molecular mechanisms underlying MED and highlights potential therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Woods et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: